Association between the functional MHC2TA ↿68 A/G polymorphism and susceptibility to rheumatoid arthritis: a meta-analysis

详细信息    查看全文

• 作者：Young Ho Lee ; Sang-Cheol Bae
• 关键词：Meta ; analysis ; MHC2TA ; Polymorphism ; Rheumatoid arthritis
• 刊名：Clinical Rheumatology
• 出版年：2016
• 出版时间：April 2016
• 年：2016
• 卷：35
• 期：4
• 页码：901-909
• 全文大小：579 KB
• 参考文献：1.MacGregor AJ, Snieder H, Rigby AS, Koskenvuo M, Kaprio J, Aho K, Silman AJ (2000) Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum 43:30–37CrossRef PubMed
  2.Choi SJ, Rho YH, Ji JD, Song GG, Lee YH (2006) Genome scan meta-analysis of rheumatoid arthritis. Rheumatology (Oxford) 45:166–170CrossRef
  3.Friese MA, Jones EY, Fugger L (2005) MHC II molecules in inflammatory diseases: interplay of qualities and quantities. Trends Immunol 26:559–561CrossRef PubMed
  4.Ting JP, Trowsdale J (2002) Genetic control of MHC class II expression. Cell 109(Suppl):S21–S33CrossRef PubMed
  5.Swanberg M, Lidman O, Padyukov L, Eriksson P, Akesson E, Jagodic M, Lobell A, Khademi M, Borjesson O, Lindgren CM, Lundman P, Brookes AJ, Kere J, Luthman H, Alfredsson L, Hillert J, Klareskog L, Hamsten A, Piehl F, Olsson T (2005) MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction. Nat Genet 37:486–494CrossRef PubMed
  6.Eike MC, Skinningsrud B, Ronninger M, Stormyr A, Kvien TK, Joner G, Njolstad PR, Forre O, Flato B, Alfredsson L, Padyukov L, Undlien DE, Lie BA (2012) CIITA gene variants are associated with rheumatoid arthritis in Scandinavian populations. Genes Immun 13:431–436CrossRef PubMed
  7.Dieguez-Gonzalez R, Akar S, Calaza M, Gonzalez-Alvaro I, Fernandez-Gutierrez B, Lamas JR, de la Serna AR, Caliz R, Blanco FJ, Pascual-Salcedo D, Velloso ML, Perez-Pampin E, Pablos JL, Navarro F, Narvaez J, Lopez-Longo FJ, Herrero-Beaumont G, Gomez-Reino JJ, Gonzalez A (2009) Lack of association with rheumatoid arthritis of selected polymorphisms in 4 candidate genes: CFH, CD209, eotaxin-3, and MHC2TA. J Rheumatol 36:1590–1595CrossRef PubMed
  8.Plant D, Barton A, Thomson W, Ke X, Eyre S, Hinks A, Bowes J, Gibbons LJ, Wilson AG, Marinou I, Morgan AW, Steer S, Hocking LJ, Reid DM, Wordsworth P, Harrison P, Worthington J (2009) A re-evaluation of three putative functional single nucleotide polymorphisms in rheumatoid arthritis. Ann Rheum Dis 68:1373–1375CrossRef PubMed
  9.O’Doherty C, Hawkins S, Rooney M, Vandenbroeck K (2007) The MHC2TA-168A/G and +1614G/C polymorphisms and risk for multiple sclerosis or chronic inflammatory arthropathies. Tissue Antigens 70:247–251CrossRef PubMed
  10.Eyre S, Bowes J, Spreckley K, Potter C, Ring S, Strachan D, Worthington J, Barton A (2006) Investigation of the MHC2TA gene, associated with rheumatoid arthritis in a Swedish population, in a UK rheumatoid arthritis cohort. Arthritis Rheum 54:3417–3422CrossRef PubMed
  11.Martinez A, Sanchez-Lopez M, Varade J, Mas A, Martin MC, de Las Heras V, Arroyo R, Mendoza JL, Diaz-Rubio M, Fernandez-Gutierrez B, de la Concha EG, Urcelay E (2007) Role of the MHC2TA gene in autoimmune diseases. Ann Rheum Dis 66:325–329CrossRef PubMed PubMedCentral
  12.Harrison P, Pointon JJ, Farrar C, Harin A, Wordsworth BP (2007) MHC2TA promoter polymorphism (−168*G/A, rs3087456) is not associated with susceptibility to rheumatoid arthritis in British Caucasian rheumatoid arthritis patients. Rheumatology 46:409–411CrossRef PubMed
  13.Orozco G, Robledo G, Linga Reddy MV, Garcia A, Pascual-Salcedo D, Balsa A, Gonzalez-Gay MA, Eimon A, Paira S, Scherbarth HR, Pons-Estel BA, Petersson IF, Alarcon-Riquelme M, Martin J (2006) Study of the role of a functional polymorphism of MHC2TA in rheumatoid arthritis in three ethnically different populations. Rheumatology 45:1442–1444CrossRef PubMed
  14.Yazdani-Biuki B, Brickmann K, Wohlfahrt K, Mueller T, Marz W, Renner W, Gutjahr M, Langsenlehner U, Krippl P, Wascher TC, Paulweber B, Graninger W, Brezinschek HP (2006) The MHC2TA -168A > G gene polymorphism is not associated with rheumatoid arthritis in Austrian patients. Arthritis Res Ther 8:R97CrossRef PubMed PubMedCentral
  15.Akkad DA, Jagiello P, Szyld P, Goedde R, Wieczorek S, Gross WL, Epplen JT (2006) Promoter polymorphism rs3087456 in the MHC class II transactivator gene is not associated with susceptibility for selected autoimmune diseases in German patient groups. Int J Immunogenetics 33:59–61CrossRef
  16.Iikuni N, Ikari K, Momohara S, Tomatsu T, Hara M, Yamanaka H, Okamoto H, Kamatani N (2007) MHC2TA is associated with rheumatoid arthritis in Japanese patients. Ann Rheum Dis 66:274–275CrossRef PubMed PubMedCentral
  17.Lee YH, Rho YH, Choi SJ, Ji JD, Song GG (2007) PADI4 polymorphisms and rheumatoid arthritis susceptibility: a meta-analysis. Rheumatol Int 27:827–833CrossRef PubMed
  18.Lee YH, Woo JH, Choi SJ, Ji JD, Song GG (2010) Associations between osteoprotegerin polymorphisms and bone mineral density: a meta-analysis. Mol Biol Rep 37:227–234CrossRef PubMed
  19.Lee YH, Bae SC, Choi SJ, Ji JD, Song GG (2011) Associations between vitamin D receptor polymorphisms and susceptibility to rheumatoid arthritis and systemic lupus erythematosus: a meta-analysis. Mol Biol Rep 38:3643–3651CrossRef PubMed
  20.Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539–1558CrossRef PubMed
  21.Egger M, Smith GD, Phillips AN (1997) Meta-analysis: principles and procedures. BMJ 315:1533–1537CrossRef PubMed PubMedCentral
  22.DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188CrossRef PubMed
  23.Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–634CrossRef PubMed PubMedCentral
  
• 作者单位：Young Ho Lee (1)
  Sang-Cheol Bae (2)
  
  1. Division of Rheumatology, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, 73, Inchon-ro, Seongbuk-gu, Seoul, 136-705, Korea
  2. Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea
  
• 刊物类别：Medicine
• 刊物主题：Medicine & Public Health
  Rheumatology
  
• 出版者：Springer London
• ISSN：1434-9949

文摘

The aim of this study was to determine whether the functional major histocompatibility complex II transactivator (MHC2TA) −168 A/G polymorphism is associated with susceptibility to rheumatoid arthritis (RA). A meta-analysis was conducted to estimate the association between the MHC2TA−168 A/G polymorphism and RA. A total of 15 comparative studies, which included 14,158 patients and 13,642 controls, were included in the meta-analysis. Based on the meta-analysis, there was no association between RA and the MHC2TA −168 G allele in the study subjects (OR = 1.046, 95 % CI = 0.987–1.108, p = 0.130) or Caucasians (OR = 1.027, 95 % CI = 0.986–1.070, p = 0.193). However, the country-specific meta-analysis revealed an association between the MHC2TA −168 G allele and RA in the Swedish population (OR = 1.131, 95 % CI = 1.023–1.250, p = 0.016). A direct comparison between rheumatoid factor (RF)-positive and RF-negative patients revealed that the frequency of the G allele was significantly lower in RF-positive patients (OR = 0.783, 95 % CI = 0.628–0.975, p = 0.029) than in RF-negative patients. This meta-analysis demonstrated that the MHC2TA −168 A/G polymorphism is not associated with susceptibility to RA in Caucasians.